Global Bio-based Pharmaceutical Packaging Supply, Demand and Key Producers, 2026-2032
The global Bio-based Pharmaceutical Packaging market size is expected to reach $ 341 million by 2032, rising at a market growth of 11.1% CAGR during the forecast period (2026-2032).
In 2025, global production of bio-based pharmaceutical packaging stood at approximately 620,000 thousand units, with a global average market price of around $260 per thousand units. That year, total global production capacity reached 900,000 thousand units per annum, and the industry's average gross profit margin hit 29%. Bio-based pharmaceutical packaging refers to packaging materials and products manufactured wholly or partially from renewable biomass feedstocks; the bio-based carbon content is primarily derived from sources such as sugarcane, corn, cassava, vegetable oils, wood, and agricultural residues. Products include pharmaceutical bottles, caps, blister base films, packaging films, sachets, components for drug delivery devices, cartons, and pulp-based inserts. Common materials include bio-based PE, partially bio-based PET, PLA, PHA, bio-based polyamides, cellulose films, and paper-based materials.
The upstream sector primarily encompasses biomass feedstocks, bio-based chemical monomers and resins, pulp fibers, and functional additives. Sugars derived from sugarcane or corn can be further converted into bio-ethanol, ethylene, and lactic acid for the production of bio-based PE, PLA, and other polymers; castor oil can be used to produce bio-based polyamides, while wood and agricultural residues serve as raw materials for pharmaceutical cartons, cellulose films, and molded pulp inserts. Other upstream materials include barrier coatings, pharmaceutical-grade masterbatches, inks, adhesives, antistatic agents, and sealing materials; their purity, traceability, and safety regarding drug contact directly impact the packaging's regulatory compliance. The midstream sector consists mainly of companies specializing in the modification of bio-based packaging materials and manufacturers of pharmaceutical packaging, employing processes such as injection molding, blow molding, extrusion, thermoforming, film blowing, coating, printing, and pulp molding. Companies must optimize material barrier properties against water vapor and oxygen to suit specific drugs and conduct validation studies regarding migrants, extractables and leachables, drug compatibility, seal integrity, and sterilization stability. Currently, bio-based materials are best suited for solid oral dosage forms, over-the-counter (OTC) drugs, health supplements, and secondary packaging; for high-risk products such as injectables and biologics, the adoption cycle is typically longer due to stringent requirements regarding material purity and long-term stability. The downstream sector primarily includes pharmaceutical companies, biotechnology firms, pharmaceutical CDMOs, health supplement manufacturers, hospitals, pharmacies, and pharmaceutical distribution organizations. Large pharmaceutical companies typically procure bottles, caps, blister packs, and cartons from packaging material suppliers and converters, utilizing them only after undergoing supplier audits, regulatory registration and filing, and stability verification.
Decarbonization targets within pharmaceutical supply chains are the primary driver behind the development of bio-based pharmaceutical packaging. Given the high consumption volumes and predominantly single-use nature of pharmaceutical packaging, it represents a critical area for managing Scope 3 carbon emissions and reducing plastic usage. Bio-based PE, PET, and composite materials—derived from renewable feedstocks such as sugarcane, corn, vegetable oils, and cellulose—reduce reliance on fossil-based raw materials while maintaining functional performance; consequently, they are increasingly being adopted for tablet bottles, effervescent tablet tubes, pharmaceutical tubes, and certain drug delivery devices.
Policies promoting the circular economy, Extended Producer Responsibility (EPR) schemes, and sustainability requirements in healthcare procurement are also compelling packaging manufacturers to develop low-carbon products. However, while these policies emphasize packaging reduction, design-for-recyclability, and waste management, the use of bio-based materials does not automatically guarantee regulatory approval for pharmaceutical packaging applications. Unlike packaging for food or cosmetics, pharmaceutical packaging must undergo rigorous validation regarding drug compatibility, extractables and leachables, barrier properties, seal integrity, sterilization stability, and long-term storage performance. This results in longer adoption cycles and higher switching costs for customers.
Market trends indicate that the application of bio-based pharmaceutical packaging will initially expand within the sectors of over-the-counter (OTC) drugs, dietary supplements, oral solid dosage forms, and topical medications, before gradually extending to nasal sprays, ophthalmic preparations, and other drug delivery systems. Future competition will shift from the mere supply of bio-based resins to a comprehensive capability model encompassing material development, packaging manufacturing, regulatory validation, and global supply. The industry continues to face challenges such as high bio-based resin costs, limited supplies of pharmaceutical-grade raw materials, fragmented recycling systems, and potential confusion between mass-balance products and actual bio-based content. Consequently, companies capable of achieving scaled production, providing comprehensive validation data, and ensuring long-term supply reliability will be better positioned to establish competitive market advantages.
This report is a detailed and comprehensive analysis of the world market for Bio-based Pharmaceutical Packaging and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Bio-based Pharmaceutical Packaging that contribute to its increasing demand across many markets.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Bio-based Pharmaceutical Packaging market
2. What is the demand of the global Bio-based Pharmaceutical Packaging market?
3. What is the year over year growth of the global Bio-based Pharmaceutical Packaging market?
4. What is the total value of the global Bio-based Pharmaceutical Packaging market?
5. Who are the Major Players in the global Bio-based Pharmaceutical Packaging market?
6. What are the growth factors driving the market demand?
In 2025, global production of bio-based pharmaceutical packaging stood at approximately 620,000 thousand units, with a global average market price of around $260 per thousand units. That year, total global production capacity reached 900,000 thousand units per annum, and the industry's average gross profit margin hit 29%. Bio-based pharmaceutical packaging refers to packaging materials and products manufactured wholly or partially from renewable biomass feedstocks; the bio-based carbon content is primarily derived from sources such as sugarcane, corn, cassava, vegetable oils, wood, and agricultural residues. Products include pharmaceutical bottles, caps, blister base films, packaging films, sachets, components for drug delivery devices, cartons, and pulp-based inserts. Common materials include bio-based PE, partially bio-based PET, PLA, PHA, bio-based polyamides, cellulose films, and paper-based materials.
The upstream sector primarily encompasses biomass feedstocks, bio-based chemical monomers and resins, pulp fibers, and functional additives. Sugars derived from sugarcane or corn can be further converted into bio-ethanol, ethylene, and lactic acid for the production of bio-based PE, PLA, and other polymers; castor oil can be used to produce bio-based polyamides, while wood and agricultural residues serve as raw materials for pharmaceutical cartons, cellulose films, and molded pulp inserts. Other upstream materials include barrier coatings, pharmaceutical-grade masterbatches, inks, adhesives, antistatic agents, and sealing materials; their purity, traceability, and safety regarding drug contact directly impact the packaging's regulatory compliance. The midstream sector consists mainly of companies specializing in the modification of bio-based packaging materials and manufacturers of pharmaceutical packaging, employing processes such as injection molding, blow molding, extrusion, thermoforming, film blowing, coating, printing, and pulp molding. Companies must optimize material barrier properties against water vapor and oxygen to suit specific drugs and conduct validation studies regarding migrants, extractables and leachables, drug compatibility, seal integrity, and sterilization stability. Currently, bio-based materials are best suited for solid oral dosage forms, over-the-counter (OTC) drugs, health supplements, and secondary packaging; for high-risk products such as injectables and biologics, the adoption cycle is typically longer due to stringent requirements regarding material purity and long-term stability. The downstream sector primarily includes pharmaceutical companies, biotechnology firms, pharmaceutical CDMOs, health supplement manufacturers, hospitals, pharmacies, and pharmaceutical distribution organizations. Large pharmaceutical companies typically procure bottles, caps, blister packs, and cartons from packaging material suppliers and converters, utilizing them only after undergoing supplier audits, regulatory registration and filing, and stability verification.
Decarbonization targets within pharmaceutical supply chains are the primary driver behind the development of bio-based pharmaceutical packaging. Given the high consumption volumes and predominantly single-use nature of pharmaceutical packaging, it represents a critical area for managing Scope 3 carbon emissions and reducing plastic usage. Bio-based PE, PET, and composite materials—derived from renewable feedstocks such as sugarcane, corn, vegetable oils, and cellulose—reduce reliance on fossil-based raw materials while maintaining functional performance; consequently, they are increasingly being adopted for tablet bottles, effervescent tablet tubes, pharmaceutical tubes, and certain drug delivery devices.
Policies promoting the circular economy, Extended Producer Responsibility (EPR) schemes, and sustainability requirements in healthcare procurement are also compelling packaging manufacturers to develop low-carbon products. However, while these policies emphasize packaging reduction, design-for-recyclability, and waste management, the use of bio-based materials does not automatically guarantee regulatory approval for pharmaceutical packaging applications. Unlike packaging for food or cosmetics, pharmaceutical packaging must undergo rigorous validation regarding drug compatibility, extractables and leachables, barrier properties, seal integrity, sterilization stability, and long-term storage performance. This results in longer adoption cycles and higher switching costs for customers.
Market trends indicate that the application of bio-based pharmaceutical packaging will initially expand within the sectors of over-the-counter (OTC) drugs, dietary supplements, oral solid dosage forms, and topical medications, before gradually extending to nasal sprays, ophthalmic preparations, and other drug delivery systems. Future competition will shift from the mere supply of bio-based resins to a comprehensive capability model encompassing material development, packaging manufacturing, regulatory validation, and global supply. The industry continues to face challenges such as high bio-based resin costs, limited supplies of pharmaceutical-grade raw materials, fragmented recycling systems, and potential confusion between mass-balance products and actual bio-based content. Consequently, companies capable of achieving scaled production, providing comprehensive validation data, and ensuring long-term supply reliability will be better positioned to establish competitive market advantages.
Report Scope
This report studies the global Bio-based Pharmaceutical Packaging production, demand, key manufacturers, and key regions.This report is a detailed and comprehensive analysis of the world market for Bio-based Pharmaceutical Packaging and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Bio-based Pharmaceutical Packaging that contribute to its increasing demand across many markets.
Highlights and key features of the study
- Global Bio-based Pharmaceutical Packaging total production and demand, 2021-2032, (K Units)
- Global Bio-based Pharmaceutical Packaging total production value, 2021-2032, (USD Million)
- Global Bio-based Pharmaceutical Packaging production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Units), (based on production site)
- Global Bio-based Pharmaceutical Packaging consumption by region & country, CAGR, 2021-2032 & (K Units)
- U.S. VS China: Bio-based Pharmaceutical Packaging domestic production, consumption, key domestic manufacturers and share
- Global Bio-based Pharmaceutical Packaging production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Units)
- Global Bio-based Pharmaceutical Packaging production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
- Global Bio-based Pharmaceutical Packaging production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Bio-based Pharmaceutical Packaging market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.Global Bio-based Pharmaceutical Packaging Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
Market Segmentation
Global Bio-based Pharmaceutical Packaging Market, Segmentation by Type:
- Bottles
- Bags
- Caps
- Others
Global Bio-based Pharmaceutical Packaging Market, Segmentation by Material:
- Bio-based PE Packaging
- Bio-based PET Packaging
- Bio-based PLA Packaging
- Bio-based PHA Packaging
- Others
Global Bio-based Pharmaceutical Packaging Market, Segmentation by Packaging Level:
- Primary Packaging
- Secondary Packaging
Global Bio-based Pharmaceutical Packaging Market, Segmentation by Bio-based Content:
- Low Bio-based Content (0–50%)
- High Bio-based Content (over 50%)
Global Bio-based Pharmaceutical Packaging Market, Segmentation by Application:
- Oral Medicine
- Injectable Drugs
- Others
Companies Profiled:
- Sanner
- Gualapack
- CurTec
- Pont Packaging
- Bormioli Pharma
- Nissha
- Braskem
- IPL Schoeller
Key Questions Answered
1. How big is the global Bio-based Pharmaceutical Packaging market?2. What is the demand of the global Bio-based Pharmaceutical Packaging market?
3. What is the year over year growth of the global Bio-based Pharmaceutical Packaging market?
4. What is the total value of the global Bio-based Pharmaceutical Packaging market?
5. Who are the Major Players in the global Bio-based Pharmaceutical Packaging market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Bio-based Pharmaceutical Packaging Introduction
1.2 World Bio-based Pharmaceutical Packaging Supply & Forecast
1.2.1 World Bio-based Pharmaceutical Packaging Production Value (2021 & 2025 & 2032)
1.2.2 World Bio-based Pharmaceutical Packaging Production (2021-2032)
1.2.3 World Bio-based Pharmaceutical Packaging Pricing Trends (2021-2032)
1.3 World Bio-based Pharmaceutical Packaging Production by Region (Based on Production Site)
1.3.1 World Bio-based Pharmaceutical Packaging Production Value by Region (2021-2032)
1.3.2 World Bio-based Pharmaceutical Packaging Production by Region (2021-2032)
1.3.3 World Bio-based Pharmaceutical Packaging Average Price by Region (2021-2032)
1.3.4 North America Bio-based Pharmaceutical Packaging Production (2021-2032)
1.3.5 Europe Bio-based Pharmaceutical Packaging Production (2021-2032)
1.3.6 China Bio-based Pharmaceutical Packaging Production (2021-2032)
1.3.7 Japan Bio-based Pharmaceutical Packaging Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Bio-based Pharmaceutical Packaging Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Bio-based Pharmaceutical Packaging Major Market Trends
2 DEMAND SUMMARY
2.1 World Bio-based Pharmaceutical Packaging Demand (2021-2032)
2.2 World Bio-based Pharmaceutical Packaging Consumption by Region
2.2.1 World Bio-based Pharmaceutical Packaging Consumption by Region (2021-2026)
2.2.2 World Bio-based Pharmaceutical Packaging Consumption Forecast by Region (2027-2032)
2.3 United States Bio-based Pharmaceutical Packaging Consumption (2021-2032)
2.4 China Bio-based Pharmaceutical Packaging Consumption (2021-2032)
2.5 Europe Bio-based Pharmaceutical Packaging Consumption (2021-2032)
2.6 Japan Bio-based Pharmaceutical Packaging Consumption (2021-2032)
2.7 South Korea Bio-based Pharmaceutical Packaging Consumption (2021-2032)
2.8 ASEAN Bio-based Pharmaceutical Packaging Consumption (2021-2032)
2.9 India Bio-based Pharmaceutical Packaging Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Bio-based Pharmaceutical Packaging Production Value by Manufacturer (2021-2026)
3.2 World Bio-based Pharmaceutical Packaging Production by Manufacturer (2021-2026)
3.3 World Bio-based Pharmaceutical Packaging Average Price by Manufacturer (2021-2026)
3.4 Bio-based Pharmaceutical Packaging Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Bio-based Pharmaceutical Packaging Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Bio-based Pharmaceutical Packaging in 2025
3.5.3 Global Concentration Ratios (CR8) for Bio-based Pharmaceutical Packaging in 2025
3.6 Bio-based Pharmaceutical Packaging Market: Overall Company Footprint Analysis
3.6.1 Bio-based Pharmaceutical Packaging Market: Region Footprint
3.6.2 Bio-based Pharmaceutical Packaging Market: Company Product Type Footprint
3.6.3 Bio-based Pharmaceutical Packaging Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Bio-based Pharmaceutical Packaging Production Value Comparison
4.1.1 United States VS China: Bio-based Pharmaceutical Packaging Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Bio-based Pharmaceutical Packaging Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Bio-based Pharmaceutical Packaging Production Comparison
4.2.1 United States VS China: Bio-based Pharmaceutical Packaging Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Bio-based Pharmaceutical Packaging Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Bio-based Pharmaceutical Packaging Consumption Comparison
4.3.1 United States VS China: Bio-based Pharmaceutical Packaging Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Bio-based Pharmaceutical Packaging Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Bio-based Pharmaceutical Packaging Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Bio-based Pharmaceutical Packaging Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Bio-based Pharmaceutical Packaging Production Value (2021-2026)
4.4.3 United States Based Manufacturers Bio-based Pharmaceutical Packaging Production (2021-2026)
4.5 China Based Bio-based Pharmaceutical Packaging Manufacturers and Market Share
4.5.1 China Based Bio-based Pharmaceutical Packaging Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Bio-based Pharmaceutical Packaging Production Value (2021-2026)
4.5.3 China Based Manufacturers Bio-based Pharmaceutical Packaging Production (2021-2026)
4.6 Rest of World Based Bio-based Pharmaceutical Packaging Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Bio-based Pharmaceutical Packaging Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Bio-based Pharmaceutical Packaging Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Bio-based Pharmaceutical Packaging Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Bio-based Pharmaceutical Packaging Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Bottles
5.2.2 Bags
5.2.3 Caps
5.2.4 Others
5.3 Market Segment by Type
5.3.1 World Bio-based Pharmaceutical Packaging Production by Type (2021-2032)
5.3.2 World Bio-based Pharmaceutical Packaging Production Value by Type (2021-2032)
5.3.3 World Bio-based Pharmaceutical Packaging Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY MATERIAL
6.1 World Bio-based Pharmaceutical Packaging Market Size Overview by Material: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Material
6.2.1 Bio-based PE Packaging
6.2.2 Bio-based PET Packaging
6.2.3 Bio-based PLA Packaging
6.2.4 Bio-based PHA Packaging
6.2.5 Others
6.3 Market Segment by Material
6.3.1 World Bio-based Pharmaceutical Packaging Production by Material (2021-2032)
6.3.2 World Bio-based Pharmaceutical Packaging Production Value by Material (2021-2032)
6.3.3 World Bio-based Pharmaceutical Packaging Average Price by Material (2021-2032)
7 MARKET ANALYSIS BY PACKAGING LEVEL
7.1 World Bio-based Pharmaceutical Packaging Market Size Overview by Packaging Level: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Packaging Level
7.2.1 Primary Packaging
7.2.2 Secondary Packaging
7.3 Market Segment by Packaging Level
7.3.1 World Bio-based Pharmaceutical Packaging Production by Packaging Level (2021-2032)
7.3.2 World Bio-based Pharmaceutical Packaging Production Value by Packaging Level (2021-2032)
7.3.3 World Bio-based Pharmaceutical Packaging Average Price by Packaging Level (2021-2032)
8 MARKET ANALYSIS BY BIO-BASED CONTENT
8.1 World Bio-based Pharmaceutical Packaging Market Size Overview by Bio-based Content: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Bio-based Content
8.2.1 Low Bio-based Content (0–50%)
8.2.2 High Bio-based Content (over 50%)
8.3 Market Segment by Bio-based Content
8.3.1 World Bio-based Pharmaceutical Packaging Production by Bio-based Content (2021-2032)
8.3.2 World Bio-based Pharmaceutical Packaging Production Value by Bio-based Content (2021-2032)
8.3.3 World Bio-based Pharmaceutical Packaging Average Price by Bio-based Content (2021-2032)
9 MARKET ANALYSIS BY APPLICATION
9.1 World Bio-based Pharmaceutical Packaging Market Size Overview by Application: 2021 VS 2025 VS 2032
9.2 Segment Introduction by Application
9.2.1 Oral Medicine
9.2.2 Injectable Drugs
9.2.3 Others
9.3 Market Segment by Application
9.3.1 World Bio-based Pharmaceutical Packaging Production by Application (2021-2032)
9.3.2 World Bio-based Pharmaceutical Packaging Production Value by Application (2021-2032)
9.3.3 World Bio-based Pharmaceutical Packaging Average Price by Application (2021-2032)
10 COMPANY PROFILES
10.1 Sanner
10.1.1 Sanner Details
10.1.2 Sanner Major Business
10.1.3 Sanner Bio-based Pharmaceutical Packaging Product and Services
10.1.4 Sanner Bio-based Pharmaceutical Packaging Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.1.5 Sanner Recent Developments/Updates
10.1.6 Sanner Competitive Strengths & Weaknesses
10.2 Gualapack
10.2.1 Gualapack Details
10.2.2 Gualapack Major Business
10.2.3 Gualapack Bio-based Pharmaceutical Packaging Product and Services
10.2.4 Gualapack Bio-based Pharmaceutical Packaging Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.2.5 Gualapack Recent Developments/Updates
10.2.6 Gualapack Competitive Strengths & Weaknesses
10.3 CurTec
10.3.1 CurTec Details
10.3.2 CurTec Major Business
10.3.3 CurTec Bio-based Pharmaceutical Packaging Product and Services
10.3.4 CurTec Bio-based Pharmaceutical Packaging Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.3.5 CurTec Recent Developments/Updates
10.3.6 CurTec Competitive Strengths & Weaknesses
10.4 Pont Packaging
10.4.1 Pont Packaging Details
10.4.2 Pont Packaging Major Business
10.4.3 Pont Packaging Bio-based Pharmaceutical Packaging Product and Services
10.4.4 Pont Packaging Bio-based Pharmaceutical Packaging Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.4.5 Pont Packaging Recent Developments/Updates
10.4.6 Pont Packaging Competitive Strengths & Weaknesses
10.5 Bormioli Pharma
10.5.1 Bormioli Pharma Details
10.5.2 Bormioli Pharma Major Business
10.5.3 Bormioli Pharma Bio-based Pharmaceutical Packaging Product and Services
10.5.4 Bormioli Pharma Bio-based Pharmaceutical Packaging Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.5.5 Bormioli Pharma Recent Developments/Updates
10.5.6 Bormioli Pharma Competitive Strengths & Weaknesses
10.6 Nissha
10.6.1 Nissha Details
10.6.2 Nissha Major Business
10.6.3 Nissha Bio-based Pharmaceutical Packaging Product and Services
10.6.4 Nissha Bio-based Pharmaceutical Packaging Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.6.5 Nissha Recent Developments/Updates
10.6.6 Nissha Competitive Strengths & Weaknesses
10.7 Braskem
10.7.1 Braskem Details
10.7.2 Braskem Major Business
10.7.3 Braskem Bio-based Pharmaceutical Packaging Product and Services
10.7.4 Braskem Bio-based Pharmaceutical Packaging Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.7.5 Braskem Recent Developments/Updates
10.7.6 Braskem Competitive Strengths & Weaknesses
10.8 IPL Schoeller
10.8.1 IPL Schoeller Details
10.8.2 IPL Schoeller Major Business
10.8.3 IPL Schoeller Bio-based Pharmaceutical Packaging Product and Services
10.8.4 IPL Schoeller Bio-based Pharmaceutical Packaging Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.8.5 IPL Schoeller Recent Developments/Updates
10.8.6 IPL Schoeller Competitive Strengths & Weaknesses
11 INDUSTRY CHAIN ANALYSIS
11.1 Bio-based Pharmaceutical Packaging Industry Chain
11.2 Bio-based Pharmaceutical Packaging Upstream Analysis
11.2.1 Bio-based Pharmaceutical Packaging Core Raw Materials
11.2.2 Main Manufacturers of Bio-based Pharmaceutical Packaging Core Raw Materials
11.3 Midstream Analysis
11.4 Downstream Analysis
11.5 Bio-based Pharmaceutical Packaging Production Mode
11.6 Bio-based Pharmaceutical Packaging Procurement Model
11.7 Bio-based Pharmaceutical Packaging Industry Sales Model and Sales Channels
11.7.1 Bio-based Pharmaceutical Packaging Sales Model
11.7.2 Bio-based Pharmaceutical Packaging Typical Distributors
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Process and Data Source
13.3 Disclaimer
1.1 Bio-based Pharmaceutical Packaging Introduction
1.2 World Bio-based Pharmaceutical Packaging Supply & Forecast
1.2.1 World Bio-based Pharmaceutical Packaging Production Value (2021 & 2025 & 2032)
1.2.2 World Bio-based Pharmaceutical Packaging Production (2021-2032)
1.2.3 World Bio-based Pharmaceutical Packaging Pricing Trends (2021-2032)
1.3 World Bio-based Pharmaceutical Packaging Production by Region (Based on Production Site)
1.3.1 World Bio-based Pharmaceutical Packaging Production Value by Region (2021-2032)
1.3.2 World Bio-based Pharmaceutical Packaging Production by Region (2021-2032)
1.3.3 World Bio-based Pharmaceutical Packaging Average Price by Region (2021-2032)
1.3.4 North America Bio-based Pharmaceutical Packaging Production (2021-2032)
1.3.5 Europe Bio-based Pharmaceutical Packaging Production (2021-2032)
1.3.6 China Bio-based Pharmaceutical Packaging Production (2021-2032)
1.3.7 Japan Bio-based Pharmaceutical Packaging Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Bio-based Pharmaceutical Packaging Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Bio-based Pharmaceutical Packaging Major Market Trends
2 DEMAND SUMMARY
2.1 World Bio-based Pharmaceutical Packaging Demand (2021-2032)
2.2 World Bio-based Pharmaceutical Packaging Consumption by Region
2.2.1 World Bio-based Pharmaceutical Packaging Consumption by Region (2021-2026)
2.2.2 World Bio-based Pharmaceutical Packaging Consumption Forecast by Region (2027-2032)
2.3 United States Bio-based Pharmaceutical Packaging Consumption (2021-2032)
2.4 China Bio-based Pharmaceutical Packaging Consumption (2021-2032)
2.5 Europe Bio-based Pharmaceutical Packaging Consumption (2021-2032)
2.6 Japan Bio-based Pharmaceutical Packaging Consumption (2021-2032)
2.7 South Korea Bio-based Pharmaceutical Packaging Consumption (2021-2032)
2.8 ASEAN Bio-based Pharmaceutical Packaging Consumption (2021-2032)
2.9 India Bio-based Pharmaceutical Packaging Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Bio-based Pharmaceutical Packaging Production Value by Manufacturer (2021-2026)
3.2 World Bio-based Pharmaceutical Packaging Production by Manufacturer (2021-2026)
3.3 World Bio-based Pharmaceutical Packaging Average Price by Manufacturer (2021-2026)
3.4 Bio-based Pharmaceutical Packaging Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Bio-based Pharmaceutical Packaging Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Bio-based Pharmaceutical Packaging in 2025
3.5.3 Global Concentration Ratios (CR8) for Bio-based Pharmaceutical Packaging in 2025
3.6 Bio-based Pharmaceutical Packaging Market: Overall Company Footprint Analysis
3.6.1 Bio-based Pharmaceutical Packaging Market: Region Footprint
3.6.2 Bio-based Pharmaceutical Packaging Market: Company Product Type Footprint
3.6.3 Bio-based Pharmaceutical Packaging Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Bio-based Pharmaceutical Packaging Production Value Comparison
4.1.1 United States VS China: Bio-based Pharmaceutical Packaging Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Bio-based Pharmaceutical Packaging Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Bio-based Pharmaceutical Packaging Production Comparison
4.2.1 United States VS China: Bio-based Pharmaceutical Packaging Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Bio-based Pharmaceutical Packaging Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Bio-based Pharmaceutical Packaging Consumption Comparison
4.3.1 United States VS China: Bio-based Pharmaceutical Packaging Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Bio-based Pharmaceutical Packaging Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Bio-based Pharmaceutical Packaging Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Bio-based Pharmaceutical Packaging Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Bio-based Pharmaceutical Packaging Production Value (2021-2026)
4.4.3 United States Based Manufacturers Bio-based Pharmaceutical Packaging Production (2021-2026)
4.5 China Based Bio-based Pharmaceutical Packaging Manufacturers and Market Share
4.5.1 China Based Bio-based Pharmaceutical Packaging Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Bio-based Pharmaceutical Packaging Production Value (2021-2026)
4.5.3 China Based Manufacturers Bio-based Pharmaceutical Packaging Production (2021-2026)
4.6 Rest of World Based Bio-based Pharmaceutical Packaging Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Bio-based Pharmaceutical Packaging Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Bio-based Pharmaceutical Packaging Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Bio-based Pharmaceutical Packaging Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Bio-based Pharmaceutical Packaging Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Bottles
5.2.2 Bags
5.2.3 Caps
5.2.4 Others
5.3 Market Segment by Type
5.3.1 World Bio-based Pharmaceutical Packaging Production by Type (2021-2032)
5.3.2 World Bio-based Pharmaceutical Packaging Production Value by Type (2021-2032)
5.3.3 World Bio-based Pharmaceutical Packaging Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY MATERIAL
6.1 World Bio-based Pharmaceutical Packaging Market Size Overview by Material: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Material
6.2.1 Bio-based PE Packaging
6.2.2 Bio-based PET Packaging
6.2.3 Bio-based PLA Packaging
6.2.4 Bio-based PHA Packaging
6.2.5 Others
6.3 Market Segment by Material
6.3.1 World Bio-based Pharmaceutical Packaging Production by Material (2021-2032)
6.3.2 World Bio-based Pharmaceutical Packaging Production Value by Material (2021-2032)
6.3.3 World Bio-based Pharmaceutical Packaging Average Price by Material (2021-2032)
7 MARKET ANALYSIS BY PACKAGING LEVEL
7.1 World Bio-based Pharmaceutical Packaging Market Size Overview by Packaging Level: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Packaging Level
7.2.1 Primary Packaging
7.2.2 Secondary Packaging
7.3 Market Segment by Packaging Level
7.3.1 World Bio-based Pharmaceutical Packaging Production by Packaging Level (2021-2032)
7.3.2 World Bio-based Pharmaceutical Packaging Production Value by Packaging Level (2021-2032)
7.3.3 World Bio-based Pharmaceutical Packaging Average Price by Packaging Level (2021-2032)
8 MARKET ANALYSIS BY BIO-BASED CONTENT
8.1 World Bio-based Pharmaceutical Packaging Market Size Overview by Bio-based Content: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Bio-based Content
8.2.1 Low Bio-based Content (0–50%)
8.2.2 High Bio-based Content (over 50%)
8.3 Market Segment by Bio-based Content
8.3.1 World Bio-based Pharmaceutical Packaging Production by Bio-based Content (2021-2032)
8.3.2 World Bio-based Pharmaceutical Packaging Production Value by Bio-based Content (2021-2032)
8.3.3 World Bio-based Pharmaceutical Packaging Average Price by Bio-based Content (2021-2032)
9 MARKET ANALYSIS BY APPLICATION
9.1 World Bio-based Pharmaceutical Packaging Market Size Overview by Application: 2021 VS 2025 VS 2032
9.2 Segment Introduction by Application
9.2.1 Oral Medicine
9.2.2 Injectable Drugs
9.2.3 Others
9.3 Market Segment by Application
9.3.1 World Bio-based Pharmaceutical Packaging Production by Application (2021-2032)
9.3.2 World Bio-based Pharmaceutical Packaging Production Value by Application (2021-2032)
9.3.3 World Bio-based Pharmaceutical Packaging Average Price by Application (2021-2032)
10 COMPANY PROFILES
10.1 Sanner
10.1.1 Sanner Details
10.1.2 Sanner Major Business
10.1.3 Sanner Bio-based Pharmaceutical Packaging Product and Services
10.1.4 Sanner Bio-based Pharmaceutical Packaging Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.1.5 Sanner Recent Developments/Updates
10.1.6 Sanner Competitive Strengths & Weaknesses
10.2 Gualapack
10.2.1 Gualapack Details
10.2.2 Gualapack Major Business
10.2.3 Gualapack Bio-based Pharmaceutical Packaging Product and Services
10.2.4 Gualapack Bio-based Pharmaceutical Packaging Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.2.5 Gualapack Recent Developments/Updates
10.2.6 Gualapack Competitive Strengths & Weaknesses
10.3 CurTec
10.3.1 CurTec Details
10.3.2 CurTec Major Business
10.3.3 CurTec Bio-based Pharmaceutical Packaging Product and Services
10.3.4 CurTec Bio-based Pharmaceutical Packaging Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.3.5 CurTec Recent Developments/Updates
10.3.6 CurTec Competitive Strengths & Weaknesses
10.4 Pont Packaging
10.4.1 Pont Packaging Details
10.4.2 Pont Packaging Major Business
10.4.3 Pont Packaging Bio-based Pharmaceutical Packaging Product and Services
10.4.4 Pont Packaging Bio-based Pharmaceutical Packaging Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.4.5 Pont Packaging Recent Developments/Updates
10.4.6 Pont Packaging Competitive Strengths & Weaknesses
10.5 Bormioli Pharma
10.5.1 Bormioli Pharma Details
10.5.2 Bormioli Pharma Major Business
10.5.3 Bormioli Pharma Bio-based Pharmaceutical Packaging Product and Services
10.5.4 Bormioli Pharma Bio-based Pharmaceutical Packaging Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.5.5 Bormioli Pharma Recent Developments/Updates
10.5.6 Bormioli Pharma Competitive Strengths & Weaknesses
10.6 Nissha
10.6.1 Nissha Details
10.6.2 Nissha Major Business
10.6.3 Nissha Bio-based Pharmaceutical Packaging Product and Services
10.6.4 Nissha Bio-based Pharmaceutical Packaging Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.6.5 Nissha Recent Developments/Updates
10.6.6 Nissha Competitive Strengths & Weaknesses
10.7 Braskem
10.7.1 Braskem Details
10.7.2 Braskem Major Business
10.7.3 Braskem Bio-based Pharmaceutical Packaging Product and Services
10.7.4 Braskem Bio-based Pharmaceutical Packaging Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.7.5 Braskem Recent Developments/Updates
10.7.6 Braskem Competitive Strengths & Weaknesses
10.8 IPL Schoeller
10.8.1 IPL Schoeller Details
10.8.2 IPL Schoeller Major Business
10.8.3 IPL Schoeller Bio-based Pharmaceutical Packaging Product and Services
10.8.4 IPL Schoeller Bio-based Pharmaceutical Packaging Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.8.5 IPL Schoeller Recent Developments/Updates
10.8.6 IPL Schoeller Competitive Strengths & Weaknesses
11 INDUSTRY CHAIN ANALYSIS
11.1 Bio-based Pharmaceutical Packaging Industry Chain
11.2 Bio-based Pharmaceutical Packaging Upstream Analysis
11.2.1 Bio-based Pharmaceutical Packaging Core Raw Materials
11.2.2 Main Manufacturers of Bio-based Pharmaceutical Packaging Core Raw Materials
11.3 Midstream Analysis
11.4 Downstream Analysis
11.5 Bio-based Pharmaceutical Packaging Production Mode
11.6 Bio-based Pharmaceutical Packaging Procurement Model
11.7 Bio-based Pharmaceutical Packaging Industry Sales Model and Sales Channels
11.7.1 Bio-based Pharmaceutical Packaging Sales Model
11.7.2 Bio-based Pharmaceutical Packaging Typical Distributors
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Process and Data Source
13.3 Disclaimer
LIST OF TABLES
Table 1. World Bio-based Pharmaceutical Packaging Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Bio-based Pharmaceutical Packaging Production Value by Region (2021-2026) & (USD Million)
Table 3. World Bio-based Pharmaceutical Packaging Production Value by Region (2027-2032) & (USD Million)
Table 4. World Bio-based Pharmaceutical Packaging Production Value Market Share by Region (2021-2026)
Table 5. World Bio-based Pharmaceutical Packaging Production Value Market Share by Region (2027-2032)
Table 6. World Bio-based Pharmaceutical Packaging Production by Region (2021-2026) & (K Units)
Table 7. World Bio-based Pharmaceutical Packaging Production by Region (2027-2032) & (K Units)
Table 8. World Bio-based Pharmaceutical Packaging Production Market Share by Region (2021-2026)
Table 9. World Bio-based Pharmaceutical Packaging Production Market Share by Region (2027-2032)
Table 10. World Bio-based Pharmaceutical Packaging Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Bio-based Pharmaceutical Packaging Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Bio-based Pharmaceutical Packaging Major Market Trends
Table 13. World Bio-based Pharmaceutical Packaging Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Units)
Table 14. World Bio-based Pharmaceutical Packaging Consumption by Region (2021-2026) & (K Units)
Table 15. World Bio-based Pharmaceutical Packaging Consumption Forecast by Region (2027-2032) & (K Units)
Table 16. World Bio-based Pharmaceutical Packaging Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Bio-based Pharmaceutical Packaging Producers in 2025
Table 18. World Bio-based Pharmaceutical Packaging Production by Manufacturer (2021-2026) & (K Units)
Table 19. Production Market Share of Key Bio-based Pharmaceutical Packaging Producers in 2025
Table 20. World Bio-based Pharmaceutical Packaging Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Bio-based Pharmaceutical Packaging Company Evaluation Quadrant
Table 22. World Bio-based Pharmaceutical Packaging Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Bio-based Pharmaceutical Packaging Production Site of Key Manufacturer
Table 24. Bio-based Pharmaceutical Packaging Market: Company Product Type Footprint
Table 25. Bio-based Pharmaceutical Packaging Market: Company Product Application Footprint
Table 26. Bio-based Pharmaceutical Packaging Competitive Factors
Table 27. Bio-based Pharmaceutical Packaging New Entrant and Capacity Expansion Plans
Table 28. Bio-based Pharmaceutical Packaging Mergers & Acquisitions Activity
Table 29. United States VS China Bio-based Pharmaceutical Packaging Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Bio-based Pharmaceutical Packaging Production Comparison, (2021 & 2025 & 2032) & (K Units)
Table 31. United States VS China Bio-based Pharmaceutical Packaging Consumption Comparison, (2021 & 2025 & 2032) & (K Units)
Table 32. United States Based Bio-based Pharmaceutical Packaging Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Bio-based Pharmaceutical Packaging Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Bio-based Pharmaceutical Packaging Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Bio-based Pharmaceutical Packaging Production (2021-2026) & (K Units)
Table 36. United States Based Manufacturers Bio-based Pharmaceutical Packaging Production Market Share (2021-2026)
Table 37. China Based Bio-based Pharmaceutical Packaging Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Bio-based Pharmaceutical Packaging Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Bio-based Pharmaceutical Packaging Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Bio-based Pharmaceutical Packaging Production, (2021-2026) & (K Units)
Table 41. China Based Manufacturers Bio-based Pharmaceutical Packaging Production Market Share (2021-2026)
Table 42. Rest of World Based Bio-based Pharmaceutical Packaging Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Bio-based Pharmaceutical Packaging Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Bio-based Pharmaceutical Packaging Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Bio-based Pharmaceutical Packaging Production, (2021-2026) & (K Units)
Table 46. Rest of World Based Manufacturers Bio-based Pharmaceutical Packaging Production Market Share (2021-2026)
Table 47. World Bio-based Pharmaceutical Packaging Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Bio-based Pharmaceutical Packaging Production by Type (2021-2026) & (K Units)
Table 49. World Bio-based Pharmaceutical Packaging Production by Type (2027-2032) & (K Units)
Table 50. World Bio-based Pharmaceutical Packaging Production Value by Type (2021-2026) & (USD Million)
Table 51. World Bio-based Pharmaceutical Packaging Production Value by Type (2027-2032) & (USD Million)
Table 52. World Bio-based Pharmaceutical Packaging Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Bio-based Pharmaceutical Packaging Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Bio-based Pharmaceutical Packaging Production Value by Material, (USD Million), 2021 & 2025 & 2032
Table 55. World Bio-based Pharmaceutical Packaging Production by Material (2021-2026) & (K Units)
Table 56. World Bio-based Pharmaceutical Packaging Production by Material (2027-2032) & (K Units)
Table 57. World Bio-based Pharmaceutical Packaging Production Value by Material (2021-2026) & (USD Million)
Table 58. World Bio-based Pharmaceutical Packaging Production Value by Material (2027-2032) & (USD Million)
Table 59. World Bio-based Pharmaceutical Packaging Average Price by Material (2021-2026) & (US$/Unit)
Table 60. World Bio-based Pharmaceutical Packaging Average Price by Material (2027-2032) & (US$/Unit)
Table 61. World Bio-based Pharmaceutical Packaging Production Value by Packaging Level, (USD Million), 2021 & 2025 & 2032
Table 62. World Bio-based Pharmaceutical Packaging Production by Packaging Level (2021-2026) & (K Units)
Table 63. World Bio-based Pharmaceutical Packaging Production by Packaging Level (2027-2032) & (K Units)
Table 64. World Bio-based Pharmaceutical Packaging Production Value by Packaging Level (2021-2026) & (USD Million)
Table 65. World Bio-based Pharmaceutical Packaging Production Value by Packaging Level (2027-2032) & (USD Million)
Table 66. World Bio-based Pharmaceutical Packaging Average Price by Packaging Level (2021-2026) & (US$/Unit)
Table 67. World Bio-based Pharmaceutical Packaging Average Price by Packaging Level (2027-2032) & (US$/Unit)
Table 68. World Bio-based Pharmaceutical Packaging Production Value by Bio-based Content, (USD Million), 2021 & 2025 & 2032
Table 69. World Bio-based Pharmaceutical Packaging Production by Bio-based Content (2021-2026) & (K Units)
Table 70. World Bio-based Pharmaceutical Packaging Production by Bio-based Content (2027-2032) & (K Units)
Table 71. World Bio-based Pharmaceutical Packaging Production Value by Bio-based Content (2021-2026) & (USD Million)
Table 72. World Bio-based Pharmaceutical Packaging Production Value by Bio-based Content (2027-2032) & (USD Million)
Table 73. World Bio-based Pharmaceutical Packaging Average Price by Bio-based Content (2021-2026) & (US$/Unit)
Table 74. World Bio-based Pharmaceutical Packaging Average Price by Bio-based Content (2027-2032) & (US$/Unit)
Table 75. World Bio-based Pharmaceutical Packaging Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 76. World Bio-based Pharmaceutical Packaging Production by Application (2021-2026) & (K Units)
Table 77. World Bio-based Pharmaceutical Packaging Production by Application (2027-2032) & (K Units)
Table 78. World Bio-based Pharmaceutical Packaging Production Value by Application (2021-2026) & (USD Million)
Table 79. World Bio-based Pharmaceutical Packaging Production Value by Application (2027-2032) & (USD Million)
Table 80. World Bio-based Pharmaceutical Packaging Average Price by Application (2021-2026) & (US$/Unit)
Table 81. World Bio-based Pharmaceutical Packaging Average Price by Application (2027-2032) & (US$/Unit)
Table 82. Sanner Basic Information, Manufacturing Base and Competitors
Table 83. Sanner Major Business
Table 84. Sanner Bio-based Pharmaceutical Packaging Product and Services
Table 85. Sanner Bio-based Pharmaceutical Packaging Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 86. Sanner Recent Developments/Updates
Table 87. Sanner Competitive Strengths & Weaknesses
Table 88. Gualapack Basic Information, Manufacturing Base and Competitors
Table 89. Gualapack Major Business
Table 90. Gualapack Bio-based Pharmaceutical Packaging Product and Services
Table 91. Gualapack Bio-based Pharmaceutical Packaging Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 92. Gualapack Recent Developments/Updates
Table 93. Gualapack Competitive Strengths & Weaknesses
Table 94. CurTec Basic Information, Manufacturing Base and Competitors
Table 95. CurTec Major Business
Table 96. CurTec Bio-based Pharmaceutical Packaging Product and Services
Table 97. CurTec Bio-based Pharmaceutical Packaging Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 98. CurTec Recent Developments/Updates
Table 99. CurTec Competitive Strengths & Weaknesses
Table 100. Pont Packaging Basic Information, Manufacturing Base and Competitors
Table 101. Pont Packaging Major Business
Table 102. Pont Packaging Bio-based Pharmaceutical Packaging Product and Services
Table 103. Pont Packaging Bio-based Pharmaceutical Packaging Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 104. Pont Packaging Recent Developments/Updates
Table 105. Pont Packaging Competitive Strengths & Weaknesses
Table 106. Bormioli Pharma Basic Information, Manufacturing Base and Competitors
Table 107. Bormioli Pharma Major Business
Table 108. Bormioli Pharma Bio-based Pharmaceutical Packaging Product and Services
Table 109. Bormioli Pharma Bio-based Pharmaceutical Packaging Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 110. Bormioli Pharma Recent Developments/Updates
Table 111. Bormioli Pharma Competitive Strengths & Weaknesses
Table 112. Nissha Basic Information, Manufacturing Base and Competitors
Table 113. Nissha Major Business
Table 114. Nissha Bio-based Pharmaceutical Packaging Product and Services
Table 115. Nissha Bio-based Pharmaceutical Packaging Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 116. Nissha Recent Developments/Updates
Table 117. Nissha Competitive Strengths & Weaknesses
Table 118. Braskem Basic Information, Manufacturing Base and Competitors
Table 119. Braskem Major Business
Table 120. Braskem Bio-based Pharmaceutical Packaging Product and Services
Table 121. Braskem Bio-based Pharmaceutical Packaging Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 122. Braskem Recent Developments/Updates
Table 123. Braskem Competitive Strengths & Weaknesses
Table 124. IPL Schoeller Basic Information, Manufacturing Base and Competitors
Table 125. IPL Schoeller Major Business
Table 126. IPL Schoeller Bio-based Pharmaceutical Packaging Product and Services
Table 127. IPL Schoeller Bio-based Pharmaceutical Packaging Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 128. IPL Schoeller Recent Developments/Updates
Table 129. IPL Schoeller Competitive Strengths & Weaknesses
Table 130. Global Key Players of Bio-based Pharmaceutical Packaging Upstream (Raw Materials)
Table 131. Global Bio-based Pharmaceutical Packaging Typical Customers
Table 132. Bio-based Pharmaceutical Packaging Typical Distributors
Table 1. World Bio-based Pharmaceutical Packaging Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Bio-based Pharmaceutical Packaging Production Value by Region (2021-2026) & (USD Million)
Table 3. World Bio-based Pharmaceutical Packaging Production Value by Region (2027-2032) & (USD Million)
Table 4. World Bio-based Pharmaceutical Packaging Production Value Market Share by Region (2021-2026)
Table 5. World Bio-based Pharmaceutical Packaging Production Value Market Share by Region (2027-2032)
Table 6. World Bio-based Pharmaceutical Packaging Production by Region (2021-2026) & (K Units)
Table 7. World Bio-based Pharmaceutical Packaging Production by Region (2027-2032) & (K Units)
Table 8. World Bio-based Pharmaceutical Packaging Production Market Share by Region (2021-2026)
Table 9. World Bio-based Pharmaceutical Packaging Production Market Share by Region (2027-2032)
Table 10. World Bio-based Pharmaceutical Packaging Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Bio-based Pharmaceutical Packaging Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Bio-based Pharmaceutical Packaging Major Market Trends
Table 13. World Bio-based Pharmaceutical Packaging Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Units)
Table 14. World Bio-based Pharmaceutical Packaging Consumption by Region (2021-2026) & (K Units)
Table 15. World Bio-based Pharmaceutical Packaging Consumption Forecast by Region (2027-2032) & (K Units)
Table 16. World Bio-based Pharmaceutical Packaging Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Bio-based Pharmaceutical Packaging Producers in 2025
Table 18. World Bio-based Pharmaceutical Packaging Production by Manufacturer (2021-2026) & (K Units)
Table 19. Production Market Share of Key Bio-based Pharmaceutical Packaging Producers in 2025
Table 20. World Bio-based Pharmaceutical Packaging Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Bio-based Pharmaceutical Packaging Company Evaluation Quadrant
Table 22. World Bio-based Pharmaceutical Packaging Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Bio-based Pharmaceutical Packaging Production Site of Key Manufacturer
Table 24. Bio-based Pharmaceutical Packaging Market: Company Product Type Footprint
Table 25. Bio-based Pharmaceutical Packaging Market: Company Product Application Footprint
Table 26. Bio-based Pharmaceutical Packaging Competitive Factors
Table 27. Bio-based Pharmaceutical Packaging New Entrant and Capacity Expansion Plans
Table 28. Bio-based Pharmaceutical Packaging Mergers & Acquisitions Activity
Table 29. United States VS China Bio-based Pharmaceutical Packaging Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Bio-based Pharmaceutical Packaging Production Comparison, (2021 & 2025 & 2032) & (K Units)
Table 31. United States VS China Bio-based Pharmaceutical Packaging Consumption Comparison, (2021 & 2025 & 2032) & (K Units)
Table 32. United States Based Bio-based Pharmaceutical Packaging Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Bio-based Pharmaceutical Packaging Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Bio-based Pharmaceutical Packaging Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Bio-based Pharmaceutical Packaging Production (2021-2026) & (K Units)
Table 36. United States Based Manufacturers Bio-based Pharmaceutical Packaging Production Market Share (2021-2026)
Table 37. China Based Bio-based Pharmaceutical Packaging Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Bio-based Pharmaceutical Packaging Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Bio-based Pharmaceutical Packaging Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Bio-based Pharmaceutical Packaging Production, (2021-2026) & (K Units)
Table 41. China Based Manufacturers Bio-based Pharmaceutical Packaging Production Market Share (2021-2026)
Table 42. Rest of World Based Bio-based Pharmaceutical Packaging Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Bio-based Pharmaceutical Packaging Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Bio-based Pharmaceutical Packaging Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Bio-based Pharmaceutical Packaging Production, (2021-2026) & (K Units)
Table 46. Rest of World Based Manufacturers Bio-based Pharmaceutical Packaging Production Market Share (2021-2026)
Table 47. World Bio-based Pharmaceutical Packaging Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Bio-based Pharmaceutical Packaging Production by Type (2021-2026) & (K Units)
Table 49. World Bio-based Pharmaceutical Packaging Production by Type (2027-2032) & (K Units)
Table 50. World Bio-based Pharmaceutical Packaging Production Value by Type (2021-2026) & (USD Million)
Table 51. World Bio-based Pharmaceutical Packaging Production Value by Type (2027-2032) & (USD Million)
Table 52. World Bio-based Pharmaceutical Packaging Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Bio-based Pharmaceutical Packaging Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Bio-based Pharmaceutical Packaging Production Value by Material, (USD Million), 2021 & 2025 & 2032
Table 55. World Bio-based Pharmaceutical Packaging Production by Material (2021-2026) & (K Units)
Table 56. World Bio-based Pharmaceutical Packaging Production by Material (2027-2032) & (K Units)
Table 57. World Bio-based Pharmaceutical Packaging Production Value by Material (2021-2026) & (USD Million)
Table 58. World Bio-based Pharmaceutical Packaging Production Value by Material (2027-2032) & (USD Million)
Table 59. World Bio-based Pharmaceutical Packaging Average Price by Material (2021-2026) & (US$/Unit)
Table 60. World Bio-based Pharmaceutical Packaging Average Price by Material (2027-2032) & (US$/Unit)
Table 61. World Bio-based Pharmaceutical Packaging Production Value by Packaging Level, (USD Million), 2021 & 2025 & 2032
Table 62. World Bio-based Pharmaceutical Packaging Production by Packaging Level (2021-2026) & (K Units)
Table 63. World Bio-based Pharmaceutical Packaging Production by Packaging Level (2027-2032) & (K Units)
Table 64. World Bio-based Pharmaceutical Packaging Production Value by Packaging Level (2021-2026) & (USD Million)
Table 65. World Bio-based Pharmaceutical Packaging Production Value by Packaging Level (2027-2032) & (USD Million)
Table 66. World Bio-based Pharmaceutical Packaging Average Price by Packaging Level (2021-2026) & (US$/Unit)
Table 67. World Bio-based Pharmaceutical Packaging Average Price by Packaging Level (2027-2032) & (US$/Unit)
Table 68. World Bio-based Pharmaceutical Packaging Production Value by Bio-based Content, (USD Million), 2021 & 2025 & 2032
Table 69. World Bio-based Pharmaceutical Packaging Production by Bio-based Content (2021-2026) & (K Units)
Table 70. World Bio-based Pharmaceutical Packaging Production by Bio-based Content (2027-2032) & (K Units)
Table 71. World Bio-based Pharmaceutical Packaging Production Value by Bio-based Content (2021-2026) & (USD Million)
Table 72. World Bio-based Pharmaceutical Packaging Production Value by Bio-based Content (2027-2032) & (USD Million)
Table 73. World Bio-based Pharmaceutical Packaging Average Price by Bio-based Content (2021-2026) & (US$/Unit)
Table 74. World Bio-based Pharmaceutical Packaging Average Price by Bio-based Content (2027-2032) & (US$/Unit)
Table 75. World Bio-based Pharmaceutical Packaging Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 76. World Bio-based Pharmaceutical Packaging Production by Application (2021-2026) & (K Units)
Table 77. World Bio-based Pharmaceutical Packaging Production by Application (2027-2032) & (K Units)
Table 78. World Bio-based Pharmaceutical Packaging Production Value by Application (2021-2026) & (USD Million)
Table 79. World Bio-based Pharmaceutical Packaging Production Value by Application (2027-2032) & (USD Million)
Table 80. World Bio-based Pharmaceutical Packaging Average Price by Application (2021-2026) & (US$/Unit)
Table 81. World Bio-based Pharmaceutical Packaging Average Price by Application (2027-2032) & (US$/Unit)
Table 82. Sanner Basic Information, Manufacturing Base and Competitors
Table 83. Sanner Major Business
Table 84. Sanner Bio-based Pharmaceutical Packaging Product and Services
Table 85. Sanner Bio-based Pharmaceutical Packaging Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 86. Sanner Recent Developments/Updates
Table 87. Sanner Competitive Strengths & Weaknesses
Table 88. Gualapack Basic Information, Manufacturing Base and Competitors
Table 89. Gualapack Major Business
Table 90. Gualapack Bio-based Pharmaceutical Packaging Product and Services
Table 91. Gualapack Bio-based Pharmaceutical Packaging Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 92. Gualapack Recent Developments/Updates
Table 93. Gualapack Competitive Strengths & Weaknesses
Table 94. CurTec Basic Information, Manufacturing Base and Competitors
Table 95. CurTec Major Business
Table 96. CurTec Bio-based Pharmaceutical Packaging Product and Services
Table 97. CurTec Bio-based Pharmaceutical Packaging Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 98. CurTec Recent Developments/Updates
Table 99. CurTec Competitive Strengths & Weaknesses
Table 100. Pont Packaging Basic Information, Manufacturing Base and Competitors
Table 101. Pont Packaging Major Business
Table 102. Pont Packaging Bio-based Pharmaceutical Packaging Product and Services
Table 103. Pont Packaging Bio-based Pharmaceutical Packaging Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 104. Pont Packaging Recent Developments/Updates
Table 105. Pont Packaging Competitive Strengths & Weaknesses
Table 106. Bormioli Pharma Basic Information, Manufacturing Base and Competitors
Table 107. Bormioli Pharma Major Business
Table 108. Bormioli Pharma Bio-based Pharmaceutical Packaging Product and Services
Table 109. Bormioli Pharma Bio-based Pharmaceutical Packaging Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 110. Bormioli Pharma Recent Developments/Updates
Table 111. Bormioli Pharma Competitive Strengths & Weaknesses
Table 112. Nissha Basic Information, Manufacturing Base and Competitors
Table 113. Nissha Major Business
Table 114. Nissha Bio-based Pharmaceutical Packaging Product and Services
Table 115. Nissha Bio-based Pharmaceutical Packaging Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 116. Nissha Recent Developments/Updates
Table 117. Nissha Competitive Strengths & Weaknesses
Table 118. Braskem Basic Information, Manufacturing Base and Competitors
Table 119. Braskem Major Business
Table 120. Braskem Bio-based Pharmaceutical Packaging Product and Services
Table 121. Braskem Bio-based Pharmaceutical Packaging Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 122. Braskem Recent Developments/Updates
Table 123. Braskem Competitive Strengths & Weaknesses
Table 124. IPL Schoeller Basic Information, Manufacturing Base and Competitors
Table 125. IPL Schoeller Major Business
Table 126. IPL Schoeller Bio-based Pharmaceutical Packaging Product and Services
Table 127. IPL Schoeller Bio-based Pharmaceutical Packaging Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 128. IPL Schoeller Recent Developments/Updates
Table 129. IPL Schoeller Competitive Strengths & Weaknesses
Table 130. Global Key Players of Bio-based Pharmaceutical Packaging Upstream (Raw Materials)
Table 131. Global Bio-based Pharmaceutical Packaging Typical Customers
Table 132. Bio-based Pharmaceutical Packaging Typical Distributors
LIST OF FIGURES
Figure 1. Bio-based Pharmaceutical Packaging Picture
Figure 2. World Bio-based Pharmaceutical Packaging Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Bio-based Pharmaceutical Packaging Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Bio-based Pharmaceutical Packaging Production (2021-2032) & (K Units)
Figure 5. World Bio-based Pharmaceutical Packaging Average Price (2021-2032) & (US$/Unit)
Figure 6. World Bio-based Pharmaceutical Packaging Production Value Market Share by Region (2021-2032)
Figure 7. World Bio-based Pharmaceutical Packaging Production Market Share by Region (2021-2032)
Figure 8. North America Bio-based Pharmaceutical Packaging Production (2021-2032) & (K Units)
Figure 9. Europe Bio-based Pharmaceutical Packaging Production (2021-2032) & (K Units)
Figure 10. China Bio-based Pharmaceutical Packaging Production (2021-2032) & (K Units)
Figure 11. Japan Bio-based Pharmaceutical Packaging Production (2021-2032) & (K Units)
Figure 12. Bio-based Pharmaceutical Packaging Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Bio-based Pharmaceutical Packaging Consumption (2021-2032) & (K Units)
Figure 15. World Bio-based Pharmaceutical Packaging Consumption Market Share by Region (2021-2032)
Figure 16. United States Bio-based Pharmaceutical Packaging Consumption (2021-2032) & (K Units)
Figure 17. China Bio-based Pharmaceutical Packaging Consumption (2021-2032) & (K Units)
Figure 18. Europe Bio-based Pharmaceutical Packaging Consumption (2021-2032) & (K Units)
Figure 19. Japan Bio-based Pharmaceutical Packaging Consumption (2021-2032) & (K Units)
Figure 20. South Korea Bio-based Pharmaceutical Packaging Consumption (2021-2032) & (K Units)
Figure 21. ASEAN Bio-based Pharmaceutical Packaging Consumption (2021-2032) & (K Units)
Figure 22. India Bio-based Pharmaceutical Packaging Consumption (2021-2032) & (K Units)
Figure 23. Producer Shipments of Bio-based Pharmaceutical Packaging by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for Bio-based Pharmaceutical Packaging Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for Bio-based Pharmaceutical Packaging Markets in 2025
Figure 26. United States VS China: Bio-based Pharmaceutical Packaging Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Bio-based Pharmaceutical Packaging Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Bio-based Pharmaceutical Packaging Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers Bio-based Pharmaceutical Packaging Production Market Share 2025
Figure 30. China Based Manufacturers Bio-based Pharmaceutical Packaging Production Market Share 2025
Figure 31. Rest of World Based Manufacturers Bio-based Pharmaceutical Packaging Production Market Share 2025
Figure 32. World Bio-based Pharmaceutical Packaging Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World Bio-based Pharmaceutical Packaging Production Value Market Share by Type in 2025
Figure 34. Bottles
Figure 35. Bags
Figure 36. Caps
Figure 37. Others
Figure 38. World Bio-based Pharmaceutical Packaging Production Market Share by Type (2021-2032)
Figure 39. World Bio-based Pharmaceutical Packaging Production Value Market Share by Type (2021-2032)
Figure 40. World Bio-based Pharmaceutical Packaging Average Price by Type (2021-2032) & (US$/Unit)
Figure 41. World Bio-based Pharmaceutical Packaging Production Value by Material, (USD Million), 2021 & 2025 & 2032
Figure 42. World Bio-based Pharmaceutical Packaging Production Value Market Share by Material in 2025
Figure 43. Bio-based PE Packaging
Figure 44. Bio-based PET Packaging
Figure 45. Bio-based PLA Packaging
Figure 46. Bio-based PHA Packaging
Figure 47. Others
Figure 48. World Bio-based Pharmaceutical Packaging Production Market Share by Material (2021-2032)
Figure 49. World Bio-based Pharmaceutical Packaging Production Value Market Share by Material (2021-2032)
Figure 50. World Bio-based Pharmaceutical Packaging Average Price by Material (2021-2032) & (US$/Unit)
Figure 51. World Bio-based Pharmaceutical Packaging Production Value by Packaging Level, (USD Million), 2021 & 2025 & 2032
Figure 52. World Bio-based Pharmaceutical Packaging Production Value Market Share by Packaging Level in 2025
Figure 53. Primary Packaging
Figure 54. Secondary Packaging
Figure 55. World Bio-based Pharmaceutical Packaging Production Market Share by Packaging Level (2021-2032)
Figure 56. World Bio-based Pharmaceutical Packaging Production Value Market Share by Packaging Level (2021-2032)
Figure 57. World Bio-based Pharmaceutical Packaging Average Price by Packaging Level (2021-2032) & (US$/Unit)
Figure 58. World Bio-based Pharmaceutical Packaging Production Value by Bio-based Content, (USD Million), 2021 & 2025 & 2032
Figure 59. World Bio-based Pharmaceutical Packaging Production Value Market Share by Bio-based Content in 2025
Figure 60. Low Bio-based Content (0–50%)
Figure 61. High Bio-based Content (over 50%)
Figure 62. World Bio-based Pharmaceutical Packaging Production Market Share by Bio-based Content (2021-2032)
Figure 63. World Bio-based Pharmaceutical Packaging Production Value Market Share by Bio-based Content (2021-2032)
Figure 64. World Bio-based Pharmaceutical Packaging Average Price by Bio-based Content (2021-2032) & (US$/Unit)
Figure 65. World Bio-based Pharmaceutical Packaging Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 66. World Bio-based Pharmaceutical Packaging Production Value Market Share by Application in 2025
Figure 67. Oral Medicine
Figure 68. Injectable Drugs
Figure 69. Others
Figure 70. World Bio-based Pharmaceutical Packaging Production Market Share by Application (2021-2032)
Figure 71. World Bio-based Pharmaceutical Packaging Production Value Market Share by Application (2021-2032)
Figure 72. World Bio-based Pharmaceutical Packaging Average Price by Application (2021-2032) & (US$/Unit)
Figure 73. Bio-based Pharmaceutical Packaging Industry Chain
Figure 74. Bio-based Pharmaceutical Packaging Procurement Model
Figure 75. Bio-based Pharmaceutical Packaging Sales Model
Figure 76. Bio-based Pharmaceutical Packaging Sales Channels, Direct Sales, and Distribution
Figure 77. Methodology
Figure 78. Research Process and Data Source
Figure 1. Bio-based Pharmaceutical Packaging Picture
Figure 2. World Bio-based Pharmaceutical Packaging Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Bio-based Pharmaceutical Packaging Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Bio-based Pharmaceutical Packaging Production (2021-2032) & (K Units)
Figure 5. World Bio-based Pharmaceutical Packaging Average Price (2021-2032) & (US$/Unit)
Figure 6. World Bio-based Pharmaceutical Packaging Production Value Market Share by Region (2021-2032)
Figure 7. World Bio-based Pharmaceutical Packaging Production Market Share by Region (2021-2032)
Figure 8. North America Bio-based Pharmaceutical Packaging Production (2021-2032) & (K Units)
Figure 9. Europe Bio-based Pharmaceutical Packaging Production (2021-2032) & (K Units)
Figure 10. China Bio-based Pharmaceutical Packaging Production (2021-2032) & (K Units)
Figure 11. Japan Bio-based Pharmaceutical Packaging Production (2021-2032) & (K Units)
Figure 12. Bio-based Pharmaceutical Packaging Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Bio-based Pharmaceutical Packaging Consumption (2021-2032) & (K Units)
Figure 15. World Bio-based Pharmaceutical Packaging Consumption Market Share by Region (2021-2032)
Figure 16. United States Bio-based Pharmaceutical Packaging Consumption (2021-2032) & (K Units)
Figure 17. China Bio-based Pharmaceutical Packaging Consumption (2021-2032) & (K Units)
Figure 18. Europe Bio-based Pharmaceutical Packaging Consumption (2021-2032) & (K Units)
Figure 19. Japan Bio-based Pharmaceutical Packaging Consumption (2021-2032) & (K Units)
Figure 20. South Korea Bio-based Pharmaceutical Packaging Consumption (2021-2032) & (K Units)
Figure 21. ASEAN Bio-based Pharmaceutical Packaging Consumption (2021-2032) & (K Units)
Figure 22. India Bio-based Pharmaceutical Packaging Consumption (2021-2032) & (K Units)
Figure 23. Producer Shipments of Bio-based Pharmaceutical Packaging by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for Bio-based Pharmaceutical Packaging Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for Bio-based Pharmaceutical Packaging Markets in 2025
Figure 26. United States VS China: Bio-based Pharmaceutical Packaging Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Bio-based Pharmaceutical Packaging Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Bio-based Pharmaceutical Packaging Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers Bio-based Pharmaceutical Packaging Production Market Share 2025
Figure 30. China Based Manufacturers Bio-based Pharmaceutical Packaging Production Market Share 2025
Figure 31. Rest of World Based Manufacturers Bio-based Pharmaceutical Packaging Production Market Share 2025
Figure 32. World Bio-based Pharmaceutical Packaging Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World Bio-based Pharmaceutical Packaging Production Value Market Share by Type in 2025
Figure 34. Bottles
Figure 35. Bags
Figure 36. Caps
Figure 37. Others
Figure 38. World Bio-based Pharmaceutical Packaging Production Market Share by Type (2021-2032)
Figure 39. World Bio-based Pharmaceutical Packaging Production Value Market Share by Type (2021-2032)
Figure 40. World Bio-based Pharmaceutical Packaging Average Price by Type (2021-2032) & (US$/Unit)
Figure 41. World Bio-based Pharmaceutical Packaging Production Value by Material, (USD Million), 2021 & 2025 & 2032
Figure 42. World Bio-based Pharmaceutical Packaging Production Value Market Share by Material in 2025
Figure 43. Bio-based PE Packaging
Figure 44. Bio-based PET Packaging
Figure 45. Bio-based PLA Packaging
Figure 46. Bio-based PHA Packaging
Figure 47. Others
Figure 48. World Bio-based Pharmaceutical Packaging Production Market Share by Material (2021-2032)
Figure 49. World Bio-based Pharmaceutical Packaging Production Value Market Share by Material (2021-2032)
Figure 50. World Bio-based Pharmaceutical Packaging Average Price by Material (2021-2032) & (US$/Unit)
Figure 51. World Bio-based Pharmaceutical Packaging Production Value by Packaging Level, (USD Million), 2021 & 2025 & 2032
Figure 52. World Bio-based Pharmaceutical Packaging Production Value Market Share by Packaging Level in 2025
Figure 53. Primary Packaging
Figure 54. Secondary Packaging
Figure 55. World Bio-based Pharmaceutical Packaging Production Market Share by Packaging Level (2021-2032)
Figure 56. World Bio-based Pharmaceutical Packaging Production Value Market Share by Packaging Level (2021-2032)
Figure 57. World Bio-based Pharmaceutical Packaging Average Price by Packaging Level (2021-2032) & (US$/Unit)
Figure 58. World Bio-based Pharmaceutical Packaging Production Value by Bio-based Content, (USD Million), 2021 & 2025 & 2032
Figure 59. World Bio-based Pharmaceutical Packaging Production Value Market Share by Bio-based Content in 2025
Figure 60. Low Bio-based Content (0–50%)
Figure 61. High Bio-based Content (over 50%)
Figure 62. World Bio-based Pharmaceutical Packaging Production Market Share by Bio-based Content (2021-2032)
Figure 63. World Bio-based Pharmaceutical Packaging Production Value Market Share by Bio-based Content (2021-2032)
Figure 64. World Bio-based Pharmaceutical Packaging Average Price by Bio-based Content (2021-2032) & (US$/Unit)
Figure 65. World Bio-based Pharmaceutical Packaging Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 66. World Bio-based Pharmaceutical Packaging Production Value Market Share by Application in 2025
Figure 67. Oral Medicine
Figure 68. Injectable Drugs
Figure 69. Others
Figure 70. World Bio-based Pharmaceutical Packaging Production Market Share by Application (2021-2032)
Figure 71. World Bio-based Pharmaceutical Packaging Production Value Market Share by Application (2021-2032)
Figure 72. World Bio-based Pharmaceutical Packaging Average Price by Application (2021-2032) & (US$/Unit)
Figure 73. Bio-based Pharmaceutical Packaging Industry Chain
Figure 74. Bio-based Pharmaceutical Packaging Procurement Model
Figure 75. Bio-based Pharmaceutical Packaging Sales Model
Figure 76. Bio-based Pharmaceutical Packaging Sales Channels, Direct Sales, and Distribution
Figure 77. Methodology
Figure 78. Research Process and Data Source
